Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Integrin alpha-IIb (αIIb or CD41) is a protein that combines with the beta-3 subunit to form the αIIbβ3 complex, a major receptor on platelets. It plays a critical role in hemostasis and thrombosis by mediating platelet aggregation through interactions with ligands like fibrinogen. Mutations in ITGA2B cause Glanzmann thrombasthenia. Antagonists targeting αIIbβ3 are used as antithrombotic agents.
Antagonism of αIIbβ3 interaction with ligands like fibrinogen, preventing platelet aggregation
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Integrin alpha-IIb (αIIb).